Abacus Medicine appoints Managing Director for Aposave
Simon Estcourt to head global activities for Aposave, the Abacus Medicine group’s pharmaceutical services company
Abacus Medicine continues to develop and expand its business and is now making further inroads in the market for pharmaceutical services.
The company has appointed Mr. Simon Estcourt as the new Managing Director for the global Aposave business, which serves its customers from offices in Denmark, Hong Kong, the UK, and the US. Simon Estcourt has previously served as Chief Strategy Officer with the Clinigen Group and as President, Managed Access Programs Division at IDIS.
CEO of Abacus Medicine, Flemming Wagner says: “Simon brings unrivalled industry knowledge and is a great addition to our team. Our early results in the Aposave business have been very promising, and with Simon onboard, we will be able to accelerate it to the next level.”
Simon Estcourt says: “Abacus Medicine is a uniquely ambitious and dynamic company with a truly modern, diverse and global mindset. I am excited to join the organization and for the opportunity to lead the Aposave team.”
Aposave has developed a market leading range of services focused on providing access to medicines around the world. Working across the lifecycle in partnership with pharmaceutical and biotechnology companies Aposave creates and delivers innovative solutions that ensure patients can get timely access to the medicines they need, whilst helping pharmaceutical and biotechnology companies achieve their clinical and commercial objectives.
Building on a proven platform
Over the past years, Abacus Medicine has shown strong financial performance, characterised by high, organic growth and profitability at robust margins. During the period of 2015 to 2017, revenues grew by approximately 50% on average per year to reach EUR 253.1 million for the full year 2017.
The steep growth trajectory continued in the first six months of 2018 with revenue growth of approximately 42% compared to the first six months of 2017.
Through Aposave, Abacus Medicine aims to leverage its proven growth platform in the related market for pharmaceutical services, providing medicine access solutions across the product lifecycle.
Visit Aposave here.
Wir helfen gerne, also scheuen Sie sich bitte nicht, uns bei Fragen zu kontaktieren. Untenstehend finden Sie unsere Hauptniederlassungen, in denen unsere Mitarbeiter aus ganz Europa arbeiten.
1620 Copenhagen V
Maglódi út 6
Berliner Straße 8
The Leadenhall Building,
122 Leadenhall Street,
London EC3V 4AB
12/14 Rond-Point des Champs-Elysées
Paris 75008, France